Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells.
Inagaki N
,
Yoshida H
,
Mizuta M
,
Mizuno N
,
Fujii Y
,
Gonoi T
,
Miyazaki J
,
Seino S
.
???displayArticle.abstract??? Pituitary adenylate cyclase-activating polypeptide (PACAP) is a neuropeptide belonging to the vasoactive intestinal polypeptide/glucagon/secretin family. It is widely distributed in the body, and a variety of biological actions have been reported. PACAP exerts its biological effects by binding to specific receptors that are coupled to GTP-binding proteins. Recent studies have shown that there is a family of PACAP receptors (PACAPRs), and two members of this family have been identified. We report here the cloning, functional expression, and tissue distribution of a third PACAPR subtype, designated PACAPR-3. The cDNA encoding PACAPR-3 has been isolated from a mouse insulin-secreting beta-cell line MIN6 cDNA library. Mouse PACAPR-3 is a protein of 437 amino acids that has 50% and 51% identity with rat PACAP type I and type II receptors, respectively. Expression of recombinant mouse PACAPR-3 in mammalian cells shows that it binds to vasoactive intestinal polypeptide as well as PACAP-38 and -27, with a slightly higher affinity for PACAP-38, and is positively coupled to adenylate cyclase. The expression of PACAPR-3 in Xenopus oocytes indicates that calcium-activated chloride currents are evoked by PACAP and vasoactive intestinal polypeptide, suggesting that PACAPR-3 can also be coupled to phospholipase C. RNA blot analysis studies reveal that PACAPR-3 mRNA is expressed at high levels in MIN6, at moderate levels in pancreatic islets and other insulin-secreting cell lines, HIT-T15 and RINm5F, as well as in the lung, brain, stomach, and colon, and at low levels in the heart. Furthermore, insulin secretion from MIN6 cells is significantly stimulated by PACAP-38. These results suggest that the diverse biological effects of PACAP are mediated by a family of structurally related proteins and that PACAPR-3 participates in the regulation of insulin secretion.
Arimura,
Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes.
1991, Pubmed
Arimura,
Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes.
1991,
Pubmed
Arimura,
Pituitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of research.
1992,
Pubmed
Blondel,
Sequence and functional characterization of a third inositol trisphosphate receptor subtype, IP3R-3, expressed in pancreatic islets, kidney, gastrointestinal tract, and other tissues.
1993,
Pubmed
Dohlman,
Model systems for the study of seven-transmembrane-segment receptors.
1991,
Pubmed
Fridolf,
Pituitary adenylate cyclase-activating polypeptide (PACAP): occurrence in rodent pancreas and effects on insulin and glucagon secretion in the mouse.
1992,
Pubmed
Fukumoto,
Sequence, tissue distribution, and chromosomal localization of mRNA encoding a human glucose transporter-like protein.
1988,
Pubmed
Hashimoto,
Molecular cloning and tissue distribution of a receptor for pituitary adenylate cyclase-activating polypeptide.
1993,
Pubmed
Hosoya,
Molecular cloning and functional expression of rat cDNAs encoding the receptor for pituitary adenylate cyclase activating polypeptide (PACAP).
1993,
Pubmed
Inagaki,
c-Jun represses the human insulin promoter activity that depends on multiple cAMP response elements.
1992,
Pubmed
Inagaki,
Glucose as regulator of glucose transport activity and glucose-transporter mRNA in hamster beta-cell line.
1992,
Pubmed
Ishihara,
Molecular cloning and expression of a cDNA encoding the secretin receptor.
1991,
Pubmed
Ishihara,
Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide.
1992,
Pubmed
Jelinek,
Expression cloning and signaling properties of the rat glucagon receptor.
1993,
Pubmed
Jüppner,
A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide.
1991,
Pubmed
Kawai,
Pituitary adenylate cyclase activating polypeptide stimulates insulin release from the isolated perfused rat pancreas.
1992,
Pubmed
Kimura,
A novel peptide which stimulates adenylate cyclase: molecular cloning and characterization of the ovine and human cDNAs.
1990,
Pubmed
Lin,
Expression cloning of an adenylate cyclase-coupled calcitonin receptor.
1991,
Pubmed
Lin,
Pit-1-dependent expression of the receptor for growth hormone releasing factor mediates pituitary cell growth.
,
Pubmed
Lutz,
The VIP2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide.
1993,
Pubmed
Mayo,
Molecular cloning and expression of a pituitary-specific receptor for growth hormone-releasing hormone.
1992,
Pubmed
Miyata,
Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells.
1989,
Pubmed
Miyazaki,
Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms.
1990,
Pubmed
Morrow,
Molecular cloning and expression of a cDNA encoding a receptor for pituitary adenylate cyclase activating polypeptide (PACAP).
1993,
Pubmed
Pisegna,
Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor.
1993,
Pubmed
Seino,
Cloning of the alpha 1 subunit of a voltage-dependent calcium channel expressed in pancreatic beta cells.
1992,
Pubmed
Spengler,
Differential signal transduction by five splice variants of the PACAP receptor.
1993,
Pubmed
,
Xenbase
Thorens,
Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1.
1992,
Pubmed
Yamada,
Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney.
1992,
Pubmed
Yokota,
Molecular characterization of a functional cDNA for rat substance P receptor.
1989,
Pubmed
,
Xenbase